Kevin C. Tang, Chief Executive Officer, 10% Owner at Odonate Therapeutics, Inc. (ODT), bought 187,384 shares at $22.16 ($4.7M) on 2019-06-03, disclosed to the SEC on 2019-06-05.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $22.16 | 7,859 | $174K | 3.7% |
| 2 | $22.16 | 7,859 | $174K | 3.7% |
| 3 | $22.86 | 7,427 | $170K | 3.6% |
| 4 | $22.86 | 7,427 | $170K | 3.6% |
| 5 | $24.92 | 34,714 | $865K | 18.5% |
| 6 | $24.92 | 34,714 |
| $865K |
| 18.5% |
| 7 | $24.99 | 4,236 | $106K | 2.3% |
| 8 | $24.99 | 4,236 | $106K | 2.3% |
| 9 | $25.14 | 9,972 | $251K | 5.4% |
| 10 | $25.14 | 9,972 | $251K | 5.4% |
| 11 | $26.11 | 29,484 | $770K | 16.5% |
| 12 | $26.11 | 29,484 | $770K | 16.5% |
| Total | $24.93 avg | 187,384 | $4.7M | 100% |
| Filing → |
| ODT | BUY | 2020-12-23 | $8.4M | — | Filing → |
| LJPC | BUY | 2020-08-14 | $3.2M | — | Filing → |
| LJPC | BUY | 2020-02-03 | $1.7M | — | Filing → |